Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › San Francisco › NPI 1083648810

City & County of San Francisco

City & County of San Francisco was paid $56.42M by Medicaid between Jan 2018 and Dec 2024, across 642 billing codes. Its largest line is T2033, Residential care, not otherwise specified (nos), waiver; per diem — 18% of everything it billed.

33Billing provider infoCITY & COUNTY OF SAN FRANCISCO
SAN FRANCISCO, CA 94110
33aNPI1083648810assigned 07/10/2006
33bProvider typeCase Manager/Care Coordinator
28Total paid$56.42M
24GClaims2,389,041
24DCodes billed642
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Case Manager/Care Coordinator providers in California

Rank by total paid#35 of 435
Median peer was paid$2.89M
This provider vs. median20×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ARNOLD, TIMOTHY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018647,428$2.66M
2019471,333$1.90M
2020239,019$1.05M
2021249,394$2.47M
2022264,015$6.28M
2023266,582$17.05M
2024incomplete251,270$25.00M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T2033 Residential care, not otherwise specified (nos), waiver; per diem 18% 14,584 964 $10.07M
G9008 Coordinated care fee, physician coordinated care oversight services 11% 12,172 3,713 $6.16M
0760 6.9% 87,873 77,697 $3.90M
G9012 Other specified case management service not elsewhere classified 6.6% 7,765 2,624 $3.71M
H0014 Alcohol and/or drug services; ambulatory detoxification 5.8% 3,570 1,874 $3.27M
H0043 Supported housing, per diem 4.8% 2,620 2,549 $2.70M
J9271 Injection, pembrolizumab, 1 mg 2.1% 163 69 $1.18M
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.0% 68,217 61,698 $1.12M
0450 Emergency room services 1.6% 13,841 12,569 $889K
87536 1.5% 11,890 11,664 $865K
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg 1.4% 456 402 $772K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1.1% 155,448 143,769 $595K
630 more codes
90750 1.0% 1,326 $576K
90677 <1% 2,223 $563K
Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg <1% 116 $550K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 85,353 $535K
Z7502 <1% 13,488 $512K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" <1% 118,578 $477K
80053 Comprehensive metabolic panel <1% 55,207 $447K
83036 Hemoglobin; glycosylated (A1C) <1% 53,794 $414K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 25,825 $412K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 15,891 $408K
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg <1% 114 $406K
90651 <1% 3,524 $393K
80048 Basic metabolic panel (calcium, ionized) <1% 62,074 $368K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 24,687 $363K
80061 Lipid panel <1% 35,312 $362K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 5,708 $333K
99214 Doctor's office visit, returning patient (more involved) <1% 70,650 $331K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 12,253 $324K
0002A <1% 11,929 $307K
0001A <1% 12,577 $300K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 6,522 $269K
0270 <1% 8,829 $250K
90739 <1% 696 $238K
84443 Thyroid stimulating hormone (TSH) <1% 21,501 $224K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 6,584 $204K
86780 <1% 13,132 $202K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg <1% 185 $200K
90715 <1% 6,930 $190K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 4,514 $186K
82803 <1% 12,501 $185K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 9,387 $184K
90832 Psychotherapy session, about 30 minutes <1% 2,827 $178K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 3,442 $171K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,369 $166K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 2,811 $163K
70450 Computed tomography, head or brain; without contrast material <1% 3,704 $159K
0004A <1% 6,052 $153K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies <1% 65 $152K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 10,858 $146K
Z7610 <1% 23,264 $144K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,238 $132K
86803 <1% 12,715 $130K
90791 Psychiatric diagnostic evaluation <1% 575 $130K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 715 $128K
92250 <1% 7,732 $128K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 3,434 $126K
82105 <1% 3,420 $126K
88142 <1% 9,116 $121K
J3490 Unclassified drugs <1% 13,424 $120K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 220,488 $113K
77067 Screening mammography, bilateral, including computer-aided detection <1% 3,794 $113K
67028 Intravitreal injection of a pharmacologic agent <1% 902 $107K
99283 Emergency room visit (moderate) <1% 3,291 $101K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 2,368 $100K
72125 Computed tomography, cervical spine; without contrast material <1% 1,558 $99K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 31,959 $99K
0361 <1% 661 $95K
71046 Radiologic examination, chest; 2 views <1% 11,023 $95K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 5,845 $93K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 2,602 $92K
99199 Unlisted special service, procedure or report <1% 3,785 $91K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 2,143 $91K
96375 Therapeutic injection; each additional sequential IV push <1% 4,557 $88K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 2,635 $88K
80076 <1% 21,665 $86K
85027 <1% 24,625 $83K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 3,931 $82K
74183 <1% 437 $81K
99188 <1% 3,163 $79K
99201 <1% 1,381 $75K
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg <1% 158 $75K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,497 $71K
92134 <1% 7,777 $70K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,905 $67K
82728 <1% 6,785 $66K
86361 <1% 4,598 $65K
Z9725 <1% 1,504 $65K
90686 <1% 14,231 $63K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 5,690 $63K
0710 <1% 1,816 $62K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,324 $61K
90619 <1% 890 $60K
59840 <1% 1,218 $59K
0360 <1% 495 $59K
83605 <1% 6,719 $58K
99284 Emergency room visit (serious) <1% 2,132 $58K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 14,480 $58K
87340 <1% 9,299 $57K
0510 <1% 6,632 $57K
90716 <1% 2,266 $57K
87086 Culture, bacterial; quantitative colony count, urine <1% 13,106 $56K
J1380 Injection, estradiol valerate, up to 10 mg <1% 1,278 $55K
59025 Fetal non-stress test <1% 3,900 $55K
0124A <1% 2,158 $55K
0064A <1% 2,180 $54K
90707 <1% 2,134 $53K
87517 <1% 3,328 $52K
88304 <1% 1,964 $52K
0761 <1% 759 $52K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,125 $52K
86706 <1% 8,230 $51K
59425 <1% 586 $49K
71045 Radiologic examination, chest; single view <1% 8,970 $49K
87088 <1% 12,997 $49K
0516 <1% 4,097 $47K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 2,143 $47K
97039 <1% 12,213 $47K
Z7500 <1% 1,712 $46K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,944 $45K
90834 Psychotherapy session, about 45 minutes <1% 919 $45K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 505 $44K
92523 <1% 864 $44K
81025 <1% 16,110 $43K
82274 <1% 5,945 $43K
82043 <1% 11,509 $42K
86141 <1% 7,026 $41K
90656 <1% 2,098 $40K
H1001 Prenatal care, at-risk enhanced service; antepartum management <1% 970 $40K
86704 <1% 4,868 $40K
82570 <1% 13,276 $40K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,097 $39K
76801 <1% 395 $39K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 1,013 $39K
87522 Neg quan hep c or qual rna <1% 2,876 $39K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 5,685 $37K
0071A <1% 1,401 $36K
0072A <1% 1,373 $36K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 543 $35K
73630 <1% 3,408 $35K
83690 <1% 9,995 $35K
92133 <1% 2,936 $34K
97139 <1% 1,162 $34K
83970 <1% 2,135 $33K
90633 <1% 3,906 $33K
88112 <1% 995 $33K
11721 <1% 1,873 $32K
84466 <1% 4,631 $32K
86360 <1% 1,577 $31K
90670 <1% 4,736 $31K
76813 <1% 585 $31K
86708 <1% 5,125 $31K
84439 <1% 5,900 $31K
84484 <1% 5,933 $30K
99203 Doctor's office visit, new patient (routine) <1% 1,983 $30K
99152 <1% 2,761 $30K
84153 <1% 2,560 $30K
J2400 Injection, chloroprocaine hydrochloride, per 30 ml <1% 1,374 $29K
96523 <1% 1,930 $28K
96361 Intravenous infusion, hydration; each additional hour <1% 2,176 $28K
0012A <1% 1,118 $28K
59841 <1% 566 $28K
82948 <1% 15,323 $27K
70486 <1% 623 $27K
0011A <1% 1,340 $27K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,325 $27K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,711 $27K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 511 $26K
86592 <1% 17,750 $26K
81001 <1% 15,652 $26K
99232 Hospital visit by a doctor, follow-up day <1% 197 $26K
99215 Doctor's office visit, returning patient (complex) <1% 3,781 $26K
86762 <1% 2,237 $26K
73130 <1% 2,237 $25K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 226 $24K
90680 <1% 3,170 $24K
72141 <1% 374 $24K
81002 <1% 14,491 $24K
90472 Immunization administration, each additional vaccine (list separately) <1% 1,319 $23K
70551 Magnetic resonance imaging, brain; without contrast material <1% 510 $23K
72100 <1% 1,901 $23K
85610 <1% 13,364 $23K
86787 <1% 2,130 $23K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 7,294 $22K
80074 <1% 227 $22K
83880 <1% 2,954 $22K
85730 <1% 7,351 $21K
90647 <1% 3,390 $21K
97750 <1% 3,675 $20K
73030 <1% 2,133 $20K
92002 <1% 886 $20K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 8,589 $20K
88141 <1% 1,894 $19K
83735 <1% 7,931 $19K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 277 $19K
73110 <1% 1,719 $18K
84403 <1% 1,448 $18K
59430 <1% 1,416 $18K
80069 <1% 3,787 $18K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,694 $18K
0134A <1% 716 $18K
83655 <1% 4,875 $18K
83540 <1% 5,431 $18K
0031A <1% 664 $17K
99070 <1% 726 $17K
90837 Psychotherapy session, about an hour <1% 364 $17K
87081 <1% 3,874 $17K
90723 <1% 3,171 $17K
97597 <1% 380 $17K
83020 <1% 1,198 $16K
0003A <1% 622 $16K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 267 $16K
86901 <1% 6,422 $16K
87529 <1% 160 $16K
59426 <1% 9,998 $16K
86850 <1% 3,728 $15K
20610 <1% 574 $15K
87077 <1% 2,704 $15K
70355 <1% 2,005 $15K
76830 Ultrasound, transvaginal <1% 1,125 $15K
82607 <1% 3,362 $15K
97802 <1% 3,488 $15K
71250 <1% 804 $15K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,131 $15K
93976 <1% 416 $14K
86900 <1% 6,485 $14K
87430 <1% 2,337 $13K
29581 <1% 2,378 $13K
90700 <1% 1,461 $13K
99401 <1% 4,184 $13K
97165 <1% 141 $12K
90697 <1% 498 $12K
90746 <1% 976 $12K
92015 Determination of refractive state <1% 2,418 $12K
82248 <1% 4,045 $12K
87210 <1% 3,471 $12K
70498 <1% 168 $11K
90710 <1% 1,263 $11K
73610 <1% 1,578 $11K
73562 <1% 1,121 $11K
96900 <1% 566 $11K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,688 $11K
84460 <1% 4,644 $11K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,802 $10K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 3,655 $10K
73564 <1% 1,245 $10K
92558 <1% 1,390 $9K
96415 <1% 2,048 $9K
90696 <1% 1,191 $9K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 263 $9K
90713 <1% 327 $9K
92083 <1% 1,009 $9K
85018 <1% 4,599 $8K
84132 <1% 7,251 $8K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,013 $8K
A4268 Contraceptive supply, condom, female, each <1% 755 $8K
82947 <1% 3,929 $8K
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 834 $8K
84295 <1% 6,488 $8K
85014 <1% 7,807 $8K
J8540 Dexamethasone, oral, 0.25 mg <1% 2,337 $8K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) <1% 23 $8K
85652 <1% 5,901 $8K
87186 <1% 2,274 $8K
52000 <1% 80 $8K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 18,119 $8K
84450 <1% 3,259 $8K
93971 <1% 514 $7K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 2,301 $7K
73080 <1% 818 $7K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 1,507 $7K
90714 <1% 255 $7K
82610 <1% 261 $7K
76998 <1% 52 $7K
86580 <1% 2,034 $7K
83516 <1% 1,170 $7K
90732 <1% 510 $6K
P9057 Red blood cells, frozen/deglycerolized/washed, leukocytes reduced, irradiated, each unit <1% 56 $6K
86160 <1% 776 $6K
86593 <1% 2,146 $6K
82950 <1% 1,531 $6K
77066 Tomosynthesis, mammo <1% 447 $6K
84702 <1% 2,013 $6K
88342 <1% 558 $6K
86038 <1% 1,340 $6K
76770 <1% 669 $6K
88312 <1% 1,033 $6K
76642 <1% 885 $6K
H1011 Family assessment by licensed behavioral health professional for state defined purposes <1% 66 $6K
73502 <1% 836 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,158 $5K
99241 <1% 814 $5K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 509 $5K
36415 Collection of venous blood by venipuncture <1% 12,799 $5K
73120 <1% 948 $5K
84481 <1% 1,314 $5K
J2560 Injection, phenobarbital sodium, up to 120 mg <1% 175 $5K
84100 <1% 3,646 $5K
86682 <1% 259 $5K
86765 <1% 581 $5K
36000 <1% 3,465 $5K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 223 $5K
73100 <1% 632 $5K
73560 <1% 1,145 $5K
93247 <1% 24 $5K
87631 <1% 424 $5K
81003 <1% 4,116 $5K
86480 <1% 809 $4K
87070 <1% 1,353 $4K
70496 <1% 108 $4K
J2704 Injection, propofol, 10 mg <1% 1,216 $4K
82565 <1% 4,945 $4K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 1,423 $4K
84156 <1% 2,306 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,111 $4K
72052 <1% 112 $4K
Z1034 <1% 57 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 472 $4K
96417 <1% 1,013 $4K
0082A <1% 146 $4K
J1756 Injection, iron sucrose, 1 mg <1% 99 $4K
99153 Mod sedat endo service >5yrs <1% 601 $4K
29125 <1% 500 $4K
J2401 Injection, chloroprocaine hydrochloride, per 1 mg <1% 342 $4K
73620 <1% 608 $4K
86735 <1% 456 $4K
94729 <1% 843 $4K
87177 <1% 1,131 $3K
82550 <1% 1,378 $3K
73600 <1% 534 $3K
J9190 Injection, fluorouracil, 500 mg <1% 85 $3K
87209 <1% 219 $3K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 3,351 $3K
90744 <1% 226 $3K
90480 <1% 121 $3K
58300 <1% 430 $3K
82784 <1% 770 $3K
84165 <1% 1,169 $3K
88173 <1% 284 $3K
73590 <1% 667 $3K
76536 <1% 463 $3K
86920 <1% 138 $3K
83001 <1% 441 $3K
0034A <1% 108 $3K
87205 <1% 1,833 $3K
94010 <1% 1,093 $3K
94726 <1% 657 $3K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,210 $3K
83883 <1% 766 $3K
70491 <1% 71 $3K
0154A <1% 99 $3K
84999 <1% 710 $3K
73090 <1% 499 $2K
77065 Tomosynthesis, mammo <1% 251 $2K
84146 <1% 721 $2K
12011 <1% 248 $2K
0074A <1% 90 $2K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 963 $2K
92551 <1% 3,063 $2K
83021 <1% 632 $2K
72170 <1% 452 $2K
86677 <1% 886 $2K
99173 <1% 3,864 $2K
84550 <1% 1,630 $2K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 882 $2K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 352 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 877 $2K
82247 <1% 1,792 $2K
93000 <1% 551 $2K
99285 Emergency room visit (most serious) <1% 1,238 $2K
90381 <1% 86 $2K
H1003 Prenatal care, at-risk enhanced service; education <1% 1,870 $2K
84154 <1% 152 $2K
74178 <1% 118 $2K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 227 $2K
87040 <1% 636 $2K
72070 <1% 267 $2K
0013A <1% 75 $2K
85045 <1% 871 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 80 $2K
76870 <1% 285 $2K
86225 <1% 447 $2K
87902 <1% 207 $2K
99205 Prolong outpt/office vis <1% 712 $2K
88313 <1% 242 $2K
99204 Doctor's office visit, new patient (more involved) <1% 204 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,948 $2K
J0461 Injection, atropine sulfate, 0.01 mg <1% 1,301 $2K
90660 <1% 70 $2K
83615 <1% 852 $2K
J0780 Injection, prochlorperazine, up to 10 mg <1% 562 $2K
97803 <1% 241 $2K
94060 <1% 405 $2K
73552 <1% 195 $2K
99381 <1% 315 $2K
0112A <1% 62 $2K
10060 <1% 310 $2K
73221 <1% 57 $2K
88143 <1% 865 $2K
H1002 Prenatal care, at risk enhanced service; care coordination <1% 1,547 $2K
36400 <1% 1,338 $2K
72040 <1% 401 $2K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 413 $2K
J1610 Injection, glucagon hydrochloride, per 1 mg <1% 98 $1K
91320 <1% 15 $1K
99218 <1% 63 $1K
86705 <1% 107 $1K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 203 $1K
12001 <1% 243 $1K
J2060 Injection, lorazepam, 2 mg <1% 828 $1K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 781 $1K
93229 <1% 460 $1K
0081A <1% 48 $1K
72156 <1% 14 $1K
93970 <1% 26 $1K
82977 <1% 509 $1K
29705 <1% 331 $1K
J3475 Injection, magnesium sulfate, per 500 mg <1% 335 $1K
72146 <1% 14 $1K
11056 <1% 130 $1K
94664 <1% 89 $1K
90734 <1% 1,362 $1K
88307 <1% 84 $1K
87252 <1% 289 $1K
73700 <1% 26 $1K
73522 <1% 214 $1K
85651 <1% 705 $1K
85379 <1% 482 $1K
83718 <1% 666 $1K
93975 <1% 13 $983.45
J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose <1% 211 $969.16
87045 <1% 525 $965.69
97166 <1% 12 $906.56
0250 <1% 488 $905.13
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 788 $887.57
74018 <1% 205 $875.49
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 446 $874.78
J3489 Injection, zoledronic acid, 1 mg <1% 103 $856.41
Z7512 <1% 69 $848.65
93246 <1% 25 $827.69
A9578 Injection, gadobenate dimeglumine (multihance multipack), per ml <1% 47 $792.93
85008 <1% 3,261 $775.91
82330 <1% 268 $773.58
73140 <1% 267 $752.20
99244 Office or other outpatient consultation, moderate to high complexity <1% 112 $747.28
96368 <1% 22 $721.90
91318 <1% 27 $702.00
J2270 Injection, morphine sulfate, up to 10 mg <1% 131 $691.52
74175 <1% 95 $681.87
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 553 $681.18
J1815 Injection, insulin, per 5 units <1% 371 $642.58
73060 <1% 148 $641.93
87147 <1% 1,113 $638.53
29126 <1% 207 $599.34
99417 Prolong home eval add 15m <1% 150 $596.28
86769 <1% 145 $589.82
86431 <1% 510 $588.62
87046 <1% 1,045 $555.18
17250 <1% 13 $524.17
J7030 Infusion, normal saline solution , 1000 cc <1% 3,348 $521.21
16020 <1% 99 $498.31
82670 <1% 175 $496.48
96402 <1% 396 $488.22
92553 <1% 13 $481.77
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 790 $467.61
82810 <1% 244 $459.95
93930 <1% 14 $446.65
90672 <1% 170 $446.40
87220 <1% 450 $440.86
87493 <1% 135 $412.42
86709 <1% 26 $406.49
80320 <1% 290 $404.94
87102 <1% 302 $403.92
17110 <1% 30 $399.12
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel <1% 49 $398.59
70544 <1% 25 $396.80
29515 <1% 59 $395.08
86364 <1% 18 $394.59
71020 <1% 16 $394.12
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 371 $391.08
83520 <1% 26 $390.10
82040 <1% 802 $381.98
90853 Group psychotherapy (other than of a multiple-family group) <1% 51 $381.89
V5010 Assessment for hearing aid <1% 50 $377.95
99403 <1% 21 $373.86
87427 <1% 512 $368.69
11055 <1% 110 $362.13
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 28 $358.16
58301 <1% 83 $356.02
84075 <1% 115 $355.08
83002 <1% 181 $348.80
82378 <1% 165 $347.66
84155 <1% 677 $345.19
0173A <1% 13 $338.00
96156 <1% 159 $337.72
96150 <1% 249 $337.18
87350 <1% 398 $336.38
86256 <1% 53 $328.98
86359 <1% 61 $325.00
96401 <1% 461 $320.86
J7050 Infusion, normal saline solution, 250 cc <1% 2,763 $318.62
94662 <1% 135 $306.74
86039 <1% 193 $300.20
51798 <1% 123 $296.00
92557 <1% 79 $293.05
93270 <1% 48 $291.03
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 267 $284.11
87075 <1% 169 $283.60
96151 <1% 290 $277.38
82310 <1% 287 $271.11
69210 <1% 94 $268.74
90658 <1% 53 $249.70
11100 <1% 61 $246.96
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 216 $236.31
82103 <1% 118 $235.06
J0690 Injection, cefazolin sodium, 500 mg <1% 80 $233.26
J2210 Injection, methylergonovine maleate, up to 0.2 mg <1% 12 $232.69
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 57 $223.84
57452 <1% 34 $223.26
82390 <1% 171 $216.15
73000 <1% 32 $199.22
92567 <1% 46 $197.46
36416 <1% 516 $193.97
89051 <1% 116 $185.31
72131 <1% 12 $181.19
51741 <1% 42 $181.05
76857 <1% 47 $180.78
86200 <1% 156 $177.50
J1644 Injection, heparin sodium, per 1000 units <1% 333 $176.55
93225 <1% 90 $171.08
J1630 Injection, haloperidol, up to 5 mg <1% 109 $169.91
86707 <1% 191 $168.85
92020 <1% 24 $162.66
99242 <1% 12 $162.48
99383 <1% 83 $157.08
76604 <1% 13 $156.36
87116 <1% 147 $145.92
76000 <1% 88 $129.96
S0191 Misoprostol, oral, 200 mcg <1% 172 $124.23
29075 <1% 14 $118.55
94750 <1% 73 $113.75
31575 <1% 16 $110.55
80164 <1% 58 $110.23
99243 <1% 14 $108.98
76514 <1% 121 $103.18
81381 <1% 13 $102.97
86235 <1% 27 $102.90
84270 <1% 87 $101.04
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,053 $99.35
59200 <1% 13 $93.60
90688 <1% 929 $92.68
97168 <1% 337 $87.32
99078 <1% 20 $86.59
94760 <1% 67 $80.20
97810 <1% 15 $80.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 27 $79.07
77062 <1% 14 $78.07
84202 <1% 39 $76.80
99245 <1% 14 $76.27
86003 <1% 15 $75.00
87206 <1% 131 $74.69
87329 <1% 83 $74.52
84402 <1% 77 $71.00
17000 <1% 13 $69.80
17340 <1% 14 $53.40
80185 <1% 34 $53.07
J3360 Injection, diazepam, up to 5 mg <1% 47 $52.60
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 54 $51.52
93922 <1% 14 $50.82
J9000 Injection, doxorubicin hydrochloride, 10 mg <1% 19 $50.64
82652 <1% 14 $49.40
88172 <1% 25 $48.32
96416 <1% 60 $46.19
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 42 $45.02
86304 <1% 24 $37.42
58100 <1% 12 $25.00
J1071 Injection, testosterone cypionate, 1 mg <1% 90 $22.40
88311 <1% 17 $22.39
J1940 Injection, furosemide, up to 20 mg <1% 39 $21.42
82435 <1% 30 $20.17
10061 <1% 12 $20.00
96411 <1% 105 $17.96
82374 <1% 28 $17.86
83986 <1% 14 $12.96
87338 <1% 269 $12.92
86800 <1% 24 $11.55
94150 <1% 568 $11.02
J7060 5% dextrose/water (500 ml = 1 unit) <1% 199 $8.39
82143 <1% 41 $8.36
J3370 Injection, vancomycin hcl, 500 mg <1% 14 $7.22
84520 <1% 30 $4.82
59050 <1% 147 $3.00
95004 Percutaneous tests with allergenic extracts, immediate type reaction <1% 38 $2.97
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 181 $2.56
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 100 $2.38
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 14 $0.16
99451 0% 2,885 $0.00
0250R 0% 2,070 $0.00
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 0% 117 $0.00
D0120 Dental checkup, returning patient 0% 24 $0.00
99402 0% 34 $0.00
94200 0% 139 $0.00
96376 0% 94 $0.00
99384 0% 27 $0.00
D0230 Intraoral - periapical each additional radiographic image 0% 17 $0.00
97162 0% 79 $0.00
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 0% 635 $0.00
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 0% 143 $0.00
00000 0% 75 $0.00
92522 0% 19 $0.00
86702 0% 16 $0.00
G0008 Administration of influenza virus vaccine 0% 34 $0.00
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session 0% 42 $0.00
96409 0% 56 $0.00
92700 0% 155 $0.00
V2632 Posterior chamber intraocular lens 0% 12 $0.00
31231 0% 12 $0.00
86701 0% 16 $0.00
D1310 0% 16 $0.00
D0272 Bitewings - two radiographic images 0% 16 $0.00
87015 0% 22 $0.00
D1206 Topical application of fluoride varnish 0% 21 $0.00
J2505 Injection, pegfilgrastim, 6 mg 0% 15 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 207 $0.00
97530 Therapeutic activities, direct patient contact, each 15 minutes 0% 529 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 182 $0.00
11720 0% 12 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 154 $0.00
90685 0% 12 $0.00
0272R 0% 2,036 $0.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 0% 323 $0.00
99382 0% 77 $0.00
D0220 Intraoral - periapical first radiographic image 0% 17 $0.00
90662 0% 34 $0.00
99404 0% 165 $0.00
D1120 Dental cleaning, child 0% 18 $0.00
0296T 0% 42 $0.00
93024 0% 18 $0.00
97116 0% 30 $0.00
85999 0% 13 $0.00
97161 0% 26 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialARNOLD, TIMOTHY (DEPUTY DIRECTOR, PFS)
Same official

Other billing entities under ARNOLD, TIMOTHY

Full network →
ProviderLocationPaid
City & County of San FranciscoSan Francisco, CA$56.23M
City & County of San FranciscoSan Francisco, CA$41.61M
City & County of San FranciscoSan Francisco, CA$34.89M
City & County of San FranciscoSan Francisco, CA$27.82M
City & County of San FranciscoSan Francisco, CA$19.08M
City & County of San FranciscoSan Francisco, CA$13.11M
City & County of San FranciscoSan Francisco, CA$8.87M
City & County of San FranciscoSan Francisco, CA$8.33M
City & County of San FranciscoSan Francisco, CA$7.99M
City & County of San FranciscoSan Francisco, CA$7.85M
City & County of San FranciscoSan Francisco, CA$6.57M
City & County of San FranciscoSan Francisco, CA$4.96M
City & County of San FranciscoSan Francisco, CA$4.91M
City & County of San FranciscoSan Francisco, CA$4.17M
City & County of San FranciscoSan Francisco, CA$3.85M
City & County of San FranciscoSan Francisco, CA$2.55M
City & County of San FranciscoSan Francisco, CA$2.08M
City & County of San FranciscoSan Francisco, CA$707K
City & County of San FranciscoSan Francisco, CA$664K
City & County of San FranciscoSan Francisco, CA$562K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.